Bone-pathobolism treating agent
CA 2347107 A1 · Owner: Fujise, Nobuaki · Inventors: Fujise, Nobuaki; Masuyama, Chiharu; Higashio, Kanji
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel remedies for bone metabolic errors. These remedies comprise at least one member selected from the group consisting of osteoclastogenesis inhibitory factor (OCIF), analogs thereof and variants thereof and polysaccharides or derivatives thereof. As the polysaccharides or derivatives thereof use may be , made of heparin, dextran sulfate etc. These remedies have excellent , therapeutic effects on bone metabolic errors such as osteoporosis hypercalcemia and rheumatoid arthritis and can sustain the activities over a long time, which makes them highly useful as drugs.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 28, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 28, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 28, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.